Making new connections is vital to helping biotechs continue on their commercialisation journey. Advanced Therapies Connect is a 2 day virtual event held on September 28th and 29th, 2021, designed to help companies to create new connections that will enable to push this industry forward.

Dr Magali Taiel, Chief Medical Officer, will give an oral presentation on our lead product candidate LUMEVOQ® (GS010; lenadogene nolparvovec) as detailed below:


Tuesday 28th September

Time:  3:30 – 4:30 PM CEST

Session – Clinical Updates: Quickfire presentations from 3 therapeutics developers (10’ presentations followed by a 30’ group Q&A)

Presentation title: GenSight Biologics: development of gene therapies in Inherited Retinal Diseases